Upcoming events – Rare disease data for Sangamo and Strongbridge
Results of a phase I/II trial in Hunter syndrome will have implications for Gliead, and a Cushing's candidate will be watched for side-effects.
Kickstarting ideas
Independent, data-driven daily news and analysis on pharma, biotech and medtech.